|
|
|
|
LEADER |
02274nam a2200241Ia 4500 |
001 |
10.4314-ahs.v22i1.51 |
008 |
220630s2022 CNT 000 0 und d |
020 |
|
|
|a 16806905 (ISSN)
|
245 |
1 |
0 |
|a Serum protein concentration and amino acid profile of HIV/HBV co-infected subjects on HAART in Plateau State, Nigeria
|
260 |
|
0 |
|b Makerere University, Medical School
|c 2022
|
520 |
3 |
|
|a Background: Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) are currently two important blood-borne human pathogens of major public health concern with high prevalence rates in Africa. Objectives: The study assessed the impact of HIV and HBV mono- and co-infections on serum total protein, albumin, globulin fractions and plasma free amino acids concentrations. Methods: This was a cross-sectional study on adult (25-64 years old) patients on Highly Active Antiretroviral Therapy attending AIDS Preventive Initiative in Nigeria Centre, Jos University Teaching Hospital, Plateau State, Nigeria. It involved 80 subjects; 20 HIV/HBV co-infected, 20 each of HIV and HBV mono-infected controls, and 20 seronegative controls. Results: Significant (p<0.05) increases in total protein and gamma globulin but a reduction in albumin concentrations were observed in the HIV/HBV co-infected group. Similarly, significant (p<0.05) increases in alpha-1 and alpha-2 globulin concentrations were observed in the mono- and co-infected groups compared to the seronegative control group. There were significant (p<0.05) increases in the glucogenic, aromatic and branched-chain amino acid concentrations of the HIV/HBV co-infected subjects. Conclusion: The study suggests prognostic importance of alpha and gamma globulin fractions of serum protein as well as amino acid profile in the management of HIV/HBV co-infection. © 2022 Igwe CU et al. Licensee African Health Sciences.
|
650 |
0 |
4 |
|a Albumin
|
650 |
0 |
4 |
|a Amino acid
|
650 |
0 |
4 |
|a Globulin
|
650 |
0 |
4 |
|a Total protein
|
650 |
0 |
4 |
|a Viral infection
|
700 |
1 |
0 |
|a Ewuga, E.E.
|e author
|
700 |
1 |
0 |
|a Igwe, C.U.
|e author
|
700 |
1 |
0 |
|a Onwuliri, V.A.
|e author
|
700 |
1 |
0 |
|a Onyeocha, I.O.
|e author
|
700 |
1 |
0 |
|a Ujowundu, C.O.
|e author
|
773 |
|
|
|t African Health Sciences
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.4314/ahs.v22i1.51
|